Pathway analysis of transcriptomic data shows immunometabolic effects of vitamin D
            
                  
                        Supplementary Data
                        
                           - Supplementary Figure 1 - 
                              Overview of the analytical tools included in the workflow. (PDF 439 KB)
                           
- Supplementary Figure 2 - 
                              Common altered pathways in 1,25(OH)2D-treated THP-1, DCs, monocytes and B cells. (PDF
                              295 KB)
                           
- Supplementary Figure 3 - 
                              ClueGO analysis represented as networks in Cytoscape. (PDF 261 KB)
                           
- Supplementary Figure 4 - 
                              Effect of 1,25(OH)2D on genes associated with glycolysis and gluconeogenesis. (PDF
                              355 KB)
                           
- Supplementary Figure 5 - 
                              Effect of 1,25(OH)2D on genes associated with G1 to S cell cycle control (A) and Retinoblastoma
                              in Cancer (B). (PDF 608 KB)
                           
- Supplementary Figure 6 - 
                              Effect of 1,25(OH)2D on genes associated with apoptosis (A) and apoptosis modulation
                              by HSP70 (B). (PDF 451 KB)
                           
- Supplementary Figure 7 - 
                              Temporal effect of 1,25(OH)2D treatment in THP-1 cells. (PDF 199 KB)
                           
- Supplementary Table 1 - 
                              Experimental details of the selected microarray datasets. (PDF 282 KB)
                           
 
                 
         
            
               
                  
                  
                     
                        - 
                           
                              	
                                 Published online before print
                                 December 12, 2017,
                                 doi:
                                 10.1530/JME-17-0186
                                 
                              
                                 	    
                                    J Mol Endocrinol
                                    February 1, 2018 
                                    
                                 	    
                                    vol. 60 
                                    
                                    no. 2 
                                    
                                    95-108